Table I.
Survival outcome of patients with prostate cancer based on forkhead box M1 expression level.
| First author, year | Data source | Hazard ratio; P-value | Clinical outcome | (Refs.) |
|---|---|---|---|---|
| Cheng, 2014 | GSE16560 | P=0.049 | Overall survival | (30) |
| Ketola, 2017 | GSE21032 (Taylor dataset) | P<0.001 | Disease-free survival | (20) |
| Xu, 2022 | GEPIA | 1.9; P=0.0049 | Disease-free survival | (27) |
| Tian, 2021 | Rembrandt | P=0.0107 | Overall survival | (26) |
| Sharma, 2021 | TCGA | P<0.01 | Recurrence-free survival | (32) |
| Koo, 2023 | TCGA | 3.7; P=2.8×10-5 | Overall survival | (33) |
| Kim, 2019 | Korea prostate bank | 10.524; P=0.022 | Biochemical recurrence-free survival | (22) |
| Tian, 2021 | Private data | P=0.0125 | Overall survival | (26) |
TCGA, The Cancer Genome Atlas.